These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7821758)

  • 61. Recombinant anti-idiotypic antibodies inhibit human natural anti-glycoprotein (GP)IIb/IIIa autoantibodies.
    Escher R; Vogel M; Escher G; Miescher S; Stadler BM; Berchtold P
    J Autoimmun; 2002 Feb; 18(1):71-81. PubMed ID: 11869049
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Functional validation of ligand mimicry by anti-receptor antibodies: structural and therapeutic implications.
    Taub R; Greene MI
    Biochemistry; 1992 Aug; 31(33):7431-5. PubMed ID: 1324714
    [No Abstract]   [Full Text] [Related]  

  • 63. Enzyme inhibition by antibodies.
    Arnon R
    Acta Endocrinol Suppl (Copenh); 1975; 194():133-53. PubMed ID: 47683
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Crystal structure of two anti-porphyrin antibodies with peroxidase activity.
    Muñoz Robles V; Maréchal JD; Bahloul A; Sari MA; Mahy JP; Golinelli-Pimpaneau B
    PLoS One; 2012; 7(12):e51128. PubMed ID: 23240001
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antibody catalysis based on functional mimicry.
    Avalle B; Zanin V; Thomas D; Friboulet A
    Appl Biochem Biotechnol; 1998 Oct; 75(1):3-12. PubMed ID: 10214693
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Catalysis of esterolytic reactions by the anti-idiotypic antibody against human erythrocyte acetylcholinesterase.
    Alexandrova ES; Koralewski F; Titov MI; Demin AV; Ignatova AN; Kozyr AV; Kolesnikov AV; Tramontano A; Paul S; Thomas D; Gabibov AG; Friboulet A
    Dokl Biochem Biophys; 2001; 377():75-8. PubMed ID: 11712155
    [No Abstract]   [Full Text] [Related]  

  • 67. Anti-Idiotypic Agonistic Antibodies: Candidates for the Role of Universal Remedy.
    Stanova AK; Ryabkova VA; Utekhin SV; Shoenfeld VJ; Churilov LP; Shoenfeld Y
    Antibodies (Basel); 2020 May; 9(2):. PubMed ID: 32481667
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Structural requirements for binding to antibody of sequence variants of bradykinin.
    Spragg J; Schröder E; Stewart JM; Austen KF; Haber E
    Biochemistry; 1967 Dec; 6(12):3933-41. PubMed ID: 5299782
    [No Abstract]   [Full Text] [Related]  

  • 69. Is hydropathic complementarity involved in antigen-antibody binding?
    Boquet D; Déry O; Frobert Y; Grassi J; Couraud JY
    Mol Immunol; 1995 Mar; 32(4):303-8. PubMed ID: 7536893
    [No Abstract]   [Full Text] [Related]  

  • 70. Structural and Functional Mise en Abyme.
    Avalle B; Padiolleau-Lefevre S; Friboulet A
    Front Mol Biosci; 2019; 6():131. PubMed ID: 31850365
    [No Abstract]   [Full Text] [Related]  

  • 71. Targeted Therapies for Autoimmune Bullous Diseases: Current Status.
    Amber KT; Maglie R; Solimani F; Eming R; Hertl M
    Drugs; 2018 Oct; 78(15):1527-1548. PubMed ID: 30238396
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor Types.
    Ilieva KM; Cheung A; Mele S; Chiaruttini G; Crescioli S; Griffin M; Nakamura M; Spicer JF; Tsoka S; Lacy KE; Tutt ANJ; Karagiannis SN
    Front Immunol; 2017; 8():1911. PubMed ID: 29375561
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anti-Idiotypic Antibodies Specific to prM Monoantibody Prevent Antibody Dependent Enhancement of Dengue Virus Infection.
    Wang M; Yang F; Huang D; Huang Y; Zhang X; Wang C; Zhang S; Zhang R
    Front Cell Infect Microbiol; 2017; 7():157. PubMed ID: 28536674
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Structural basis for the recognition in an idiotype-anti-idiotype antibody complex related to celiac disease.
    Vangone A; Abdel-Azeim S; Caputo I; Sblattero D; Di Niro R; Cavallo L; Oliva R
    PLoS One; 2014; 9(7):e102839. PubMed ID: 25076134
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Generation of anti-idiotype scFv for pharmacokinetic measurement in lymphoma patients treated with chimera anti-CD22 antibody SM03.
    Zhao Q; Wong PF; Lee SS; Leung SO; Cheung WT; Wang JZ
    PLoS One; 2014; 9(5):e96697. PubMed ID: 24816427
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Model IgG monoclonal autoantibody-anti-idiotype pair for dissecting the humoral immune response to oxidized low density lipoprotein.
    Chang SH; Johns M; Boyle JJ; McConnell E; Kirkham PA; Bicknell C; Zahoor-ul-Hassan Dogar M; Edwards RJ; Gale-Grant O; Khamis R; Ramkhelawon KV; Haskard DO
    Hybridoma (Larchmt); 2012 Apr; 31(2):87-98. PubMed ID: 22509912
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dendritic cells transfected with scFv from Mab 7.B12 mimicking original antigen gp43 induces protection against experimental Paracoccidioidomycosis.
    Ferreira KS; Maranhão AQ; Garcia MC; Brígido MM; Santos SS; Lopes JD; Almeida SR
    PLoS One; 2011 Jan; 6(1):e15935. PubMed ID: 21249212
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Anti-idiotypic antibodies: a new approach in prion research.
    Colja Venturini A; Bresjanac M; Vranac T; Koren S; Narat M; Popović M; Curin Serbec V
    BMC Immunol; 2009 Mar; 10():16. PubMed ID: 19298674
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Phage anti-immune complex assay: general strategy for noncompetitive immunodetection of small molecules.
    González-Techera A; Vanrell L; Last JA; Hammock BD; González-Sapienza G
    Anal Chem; 2007 Oct; 79(20):7799-806. PubMed ID: 17845007
    [TBL] [Abstract][Full Text] [Related]  

  • 80. B and T cell responses elicited by monoclonal anti-idiotypic antibody (Ab2beta) mimicking gp43 from Paracoccidioides brasiliensis.
    Souza EB; Lopes JD; Almeida SR
    Clin Exp Immunol; 2004 Jul; 137(1):123-8. PubMed ID: 15196252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.